Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder
Public ClinicalTrials.gov record NCT00114686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind, Phase III Study to Compare the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) Versus Placebo as Adjunct Therapy With Mood Stabilizers (Lithium or Divalproex) for the Treatment of Alcohol Dependence in Patients With Bipolar I Disorder
Study identification
- NCT ID
- NCT00114686
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 350 participants
Conditions and interventions
Conditions
Interventions
- Quetiapine fumarate Drug
- divalproex Drug
- lithium Drug
Drug
Eligibility (public fields only)
- Age range
- 21 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2005
- Primary completion
- Not listed
- Completion
- Mar 31, 2007
- Last update posted
- Jan 3, 2013
2006 – 2007
United States locations
- U.S. sites
- 38
- U.S. states
- 21
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Cerritos | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | New Haven | Connecticut | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Maitland | Florida | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | Eagle | Idaho | — | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | Glen Burnie | Maryland | — | — |
| Research Site | Boston | Massachusetts | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Moorestown | New Jersey | — | — |
| Research Site | Albuquerque | New Mexico | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Staten Island | New York | — | — |
| Research Site | The Bronx | New York | — | — |
| Research Site | Chapel Hill | North Carolina | — | — |
| Research Site | Research Triangle Park | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Cleveland | Ohio | — | — |
| Research Site | Dayton | Ohio | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Media | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Pittsburgh | Pennsylvania | — | — |
| Research Site | Columbia | South Carolina | — | — |
| Research Site | Memphis | Tennessee | — | — |
| Research Site | Nashville | Tennessee | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Wichita Falls | Texas | — | — |
| Research Site | Richmond | Virginia | — | — |
| Research Site | Bellevue | Washington | — | — |
| Research Site | Kirkland | Washington | — | — |
| Research Site | Seattle | Washington | — | — |
| Research Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00114686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 3, 2013 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00114686 live on ClinicalTrials.gov.